The Ohio State University Wexner Medical Center James Cancer is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
The Ohio State University Wexner Medical Center James Cancer has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).
Sponsors: Miltenyi Biomedicine GmbH.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State University Wexner Medical Center James Cancer has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State University Wexner Medical Center James Cancer has 1 clinical trials on record, with 1 currently active. Their work covers Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).
The Ohio State University Wexner Medical Center James Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.